Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01225718 · ClinicalTrials.gov registry record
Ceftriaxone in Non-neutropenic Fever
A clinical trial of Histiocytosis and Pediatric Patients With Cancer, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 463
- Enrollment target
- 1
- Study location
NCT01225718 is a study of Histiocytosis and Pediatric Patients With Cancer that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 463 participants, below the 1,325-participant average among 5 other Histiocytosis trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01225718, a study of Histiocytosis and Pediatric Patients With Cancer, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 463 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a retrospective chart review of all patients cared for at Monroe Carell Jr. Children's Hospital at Vanderbilt including the following: * patients between 2007-2009 with malignancy, Langerhans cell histiocytosis (LCH) or hemophagocytic lymphohistiocytosis (HLH) and a central venous catheter who were under 23 years of age at time of diagnosis in order to ascertain the associated symptoms, management and outcome of all episodes of non-neutropenic fever. * to identify a subset of low-risk patients that can be safely managed without use of empiric antibiotics.
Conditions Studied
Study Locations (1)
Tennessee
- Monroe Carrell Jr. Children's Hospital at Vanderbilt - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 463 participants |
| Start Date | 2010-08 |
| Est. Completion | 2016-06-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01225718
The ClinicalTrials.gov registry entry for NCT01225718 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 463 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,325-participant average among 5 other Histiocytosis trials with a reported enrollment target (65% lower). The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Histiocytosis appearing as the primary indexed condition, and to 0 interventions.
NCT01225718 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT01225718 about?
NCT01225718 is a clinical study titled "Ceftriaxone in Non-neutropenic Fever". This is a retrospective chart review of all patients cared for at Monroe Carell Jr. Children's Hospital at Vanderbilt including the following: * patients between 2007-2009 with malignancy, Langerhans cell histiocytosis (LCH) or hemophagocytic lymphohistiocytosis (HLH) and a central venous catheter ...
What is the current status of trial NCT01225718?
This trial is currently completed. The enrollment target is 463 participants. The study started on 2010-08. Estimated completion is 2016-06-25.
What conditions does trial NCT01225718 study?
This clinical trial studies the following conditions: Histiocytosis, Pediatric Patients With Cancer.
Who is sponsoring clinical trial NCT01225718?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01225718 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Histiocytosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Histiocytic Disorder Follow-up Study
RECRUITING
-
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
RECRUITING · Phase 1
-
A Study of Memory, Thinking, and Brain Imaging in Adults With Histiocytosis
ACTIVE NOT RECRUITING
-
CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant
COMPLETED · Phase 2
-
HLA-Nonidentical Stem Cell and Natural Killer Cell Transplantation for Children Less the Two Years of Age With Hematologic Malignancies
COMPLETED · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.